Még nem toboroz
Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer
NCT07640932· 2. fázis· Yonsei University· Forrás
Contact: Hye Ryun Kim
Még nem toboroz
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
NCT07730840· 3. fázis· Asan Medical Center· Forrás
Contact: JoonNyung Heo, MD, PhD
Toboroz
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
NCT07871435· 1/2. fázis· GI Innovation, Inc.· Forrás
Contact: Sang Joon Shin, M.D., Ph.D. (principal investigator)
Toboroz
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
NCT07493304· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
NCT07340164· 2. fázis· Yonsei University· Forrás
Contact: Jung-Yun LEE, PhD.
Toboroz
Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)
NCT07147114· 4. fázis· Gachon University Gil Medical Center· Forrás
Contact: Wook-Jin Chung, MD, PhD
Toboroz
Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer
NCT07257523· 2. fázis· Yonsei University· Forrás
Contact: Ik Jae Lee
Toboroz
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Tae-Gyun Kim, Site 0060
Toboroz
mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
NCT07062536· 2. fázis· Seoul National University Bundang Hospital· Forrás
Contact: Choong kun Lee, MD, PhD
Toboroz
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
NCT07009171· 2. fázis· NeuroBiogen Co., Ltd· Forrás
Contact: Jiwon Lee, Professor
Toboroz
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634· 3. fázis· Celcuity Inc· Forrás
Contact: Nadene Zack, MS
Fut, nem toboroz
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
NCT06966479· 2. fázis· Upstream Bio Inc.· Forrás
Toboroz
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
NCT06730347· 2. fázis· MacroGenics· Forrás
Contact: Yujeong Huh
Toboroz
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
NCT07172802· 1/2. fázis· GI Innovation, Inc.· Forrás
Contact: Byoung Chul Cho, MD, PhD
Toboroz
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
NCT07246668· 2. fázis· Yonsei University· Forrás
Contact: Ik Jae Lee
Még nem toboroz
CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN
NCT06770426· 3. fázis· Yonsei University· Forrás
Toboroz
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775· 2. fázis· TORL Biotherapeutics, LLC· Forrás
Contact: Principal Investigator
Toboroz
A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)
NCT07252323· Yonsei University· Forrás
Contact: Ik Jae Lee
Meghívásos bevonás
Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases
NCT06250777· 2. fázis· Yonsei University· Forrás
Toboroz
Effects of Nutritional Support on Postoperative Delirium
NCT06467552· Yonsei University· Forrás
Contact: bon nyeo koo, MD
Fut, nem toboroz
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
NCT05948475· 3. fázis· TransThera Sciences (Nanjing), Inc.· Forrás
Fut, nem toboroz
A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension
NCT06216808· DeepQure Inc.· Forrás
Toboroz
A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
NCT06156527· 2. fázis· National Cancer Center, Korea· Forrás
Contact: Min Hee Hong, Ph,D.
Fut, nem toboroz
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267· 3. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás
Toboroz
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
NCT05394831· 1/2. fázis· J Ints Bio· Forrás
Contact: Sun Min Lim
Toboroz
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
NCT05753839· Yonsei University· Forrás
Contact: Won Sik Ham
Toboroz
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
NCT05824975· 1/2. fázis· GI Innovation, Inc.· Forrás
Contact: Byoung Chul Cho, MD, PhD
Toboroz
Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial
NCT05782777· Yonsei University· Forrás
Contact: Byeong-Keuk Kim
Toboroz
Aspirin vs Clopidogrel After TAVR
NCT05493657· Yonsei University· Forrás
Contact: Young-Guk Ko, MD, PhD
Fut, nem toboroz
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
NCT05555732· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique
NCT05488665· Yonsei University· Forrás
Contact: Byeong-Keuk Kim, MD, PhD
Toboroz
PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial
NCT05585411· Yonsei University· Forrás
Contact: TaeHoon Kim
Toboroz
Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer
NCT05444270· Yonsei University· Forrás
Contact: Yong Bae Kim
Fut, nem toboroz
Window of Opportunity Trial of Durvalumab (MEDI4736) to Identify Immune Dynamics in Operable Non-small Cell Lung Cancer (NSCLC) (MIRACLE)
NCT05206812· 2. fázis· Yonsei University· Forrás
Toboroz
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
NCT05320926· Yonsei University· Forrás
Contact: Byeong-Keuk Kim
Toboroz
Nutriomics and Artificial Intelligence Nutrition Obesity Cohort
NCT05494138· Yonsei University· Forrás
Contact: Sungha Park
Fut, nem toboroz
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
NCT05280457· 2. fázis· Yonsei University· Forrás
Fut, nem toboroz
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
NCT05286060· 2. fázis· Yonsei University· Forrás
Fut, nem toboroz
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016· 2. fázis· Amgen· Forrás
Toboroz
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
NCT04812431· 1/2. fázis· S.Biomedics Co., Ltd.· Forrás
Contact: Dong Ah Shin, MD
Toboroz
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
NCT04977453· 1/2. fázis· GI Innovation, Inc.· Forrás
Contact: Byoung Chul Cho, M.D., Ph.D. (principal investigator)
Fut, nem toboroz
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
NCT04676477· 1. fázis· Daiichi Sankyo· Forrás
Toboroz
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690· Dong-A ST Co., Ltd.· Forrás
Contact: Ho Seong Kim, M.D., Ph.D
Fut, nem toboroz
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
NCT04656652· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NCT04251052· NRG Oncology· Forrás
Contact: EUN JI NAM (principal investigator)
Toboroz
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
NCT05455918· 2. fázis· Yonsei University· Forrás
Contact: Jung Woo Han
Toboroz
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
NCT04239573· ECOG-ACRIN Cancer Research Group· Forrás
Contact: Seungmin Bang (principal investigator)
Toboroz
The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
NCT05415332· Yonsei University· Forrás
Contact: Chul-Min Ahn
Fut, nem toboroz
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects
NCT05440370· L&C Bio· Forrás
Fut, nem toboroz
Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer
NCT04416490· Boryung Pharmaceutical Co., Ltd· Forrás
Showing 50 of 54.